The role of miR-223 in breast cancer; an integrated analysis.
Yunus SahinZekiye AltanAydın KarabulutKhandakar A S M SaadatAhmet ArslanPublished in: Molecular biology reports (2023)
The results suggests that miR-223 and its targets, ANLN, DYNLT1, LRRC59, SLC12A8 and TPM3, might be reliable potential prognostic biomarkers in BRCA patients.